Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resistant Cancer”

3,630 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,630 results

Testing effectiveness (Phase 2)Study completedNCT03776812
What this trial is testing

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Ovarian CancerRecurrent Fallopian Tube CarcinomaRecurrent Primary Peritoneal Carcinoma
Corcept Therapeutics 178
Testing effectiveness (Phase 2)Looking for participantsNCT06173219
What this trial is testing

Safety and Efficacy of Radiotherapy Combined with Immunotherapy for Advanced Malignant Tumors.

Who this might be right for
Advanced Solid Tumor
China-Japan Friendship Hospital 38
Very early researchEnded earlyNCT02724202
What this trial is testing

Curcumin in Combination With 5FU for Colon Cancer

Who this might be right for
Metastatic Colon Cancer
Baylor Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT01246557
What this trial is testing

Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to Treatment

Who this might be right for
Chronic Lymphatic Leukemia
Hospital Universitari Vall d'Hebron Research Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT02607228
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate-Resistant Prostate Cancer
Gilead Sciences 31
Testing effectiveness (Phase 2)Study completedNCT00788775
What this trial is testing

Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma

Who this might be right for
Mucosal Lentiginous MelanomaAcral MelanomaMelanoma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00004912
What this trial is testing

Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss

Who this might be right for
CachexiaFatigueUnspecified Adult Solid Tumor, Protocol Specific
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT02333565
What this trial is testing

Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas

Who this might be right for
Recurrent MeningiomasResistant Meningiomas
Assistance Publique Hopitaux De Marseille 20
Not applicableActive Not RecruitingNCT04370522
What this trial is testing

Characterization of Innate Immune System in Patients With Luminal Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Spanish Breast Cancer Research Group 32
Testing effectiveness (Phase 2)Study completedNCT00052065
What this trial is testing

TLK286 in Combination With Doxil in Platinum Refractory or Resistant Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Telik 28
Early research (Phase 1)WithdrawnNCT02083536
What this trial is testing

LDFWART With Docetaxel in Patients With Platinum-Resistant Recurrent Ovarian Carcinoma

Who this might be right for
Ovarian CancerOvarian CarcinomaRecurrent Ovarian Cancer+1 more
University of Miami
Early research (Phase 1)Study completedNCT03135171
What this trial is testing

Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab

Who this might be right for
Breast Cancer
University of Michigan Rogel Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT02952534
What this trial is testing

Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
pharmaand GmbH 277
Early research (Phase 1)Ended earlyNCT01262664
What this trial is testing

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00327171
What this trial is testing

Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian Cancer

Who this might be right for
NeoplasmsCancer of the Ovary
Sanofi 218
Early research (Phase 1)Study completedNCT00846612
What this trial is testing

Pharmacokinetic Study of Avastin and Doxil in Ovarian Cancer

Who this might be right for
Ovarian Cancer
NYU Langone Health 15
Not applicableStudy completedNCT04448730
What this trial is testing

Polycystic Ovary Syndrome and BETATROPHIN

Who this might be right for
Polycystic OvaryObesity
Hatice Akkaya 73
Testing effectiveness (Phase 2)Study completedNCT00849121
What this trial is testing

Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 17
Early research (Phase 1)Study completedNCT05585034
What this trial is testing

Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more
Xencor, Inc. 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07437287
What this trial is testing

Testing Mitazalimab in Combination With Standard Chemotherapy in Immunotherapy Resistant Advanced Biliary Tract Cancers

Who this might be right for
Biliary Tract Cancer (BTC)
UNICANCER 160
Load More Results